Literature DB >> 18615169

Pregabalin augmentation to sertraline-risperidone combination in the treatment of obsessive-compulsive disorder.

Panagiotis Oulis, Vasilios G Masdrakis, Evangelos Karapoulios, Nikolaos A Karakatsanis, Anastasios V Kouzoupis, George Konstantakopoulos, Constantin R Soldatos.   

Abstract

Entities:  

Year:  2008        PMID： 18615169      PMCID： PMC2446488          DOI： 10.4088/pcc.v10n0312a

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  5 in total

Review 1.  Clinical practice. Obsessive-compulsive disorder.

Authors:  Michael A Jenike
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

2.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

Review 3.  Pregabalin: From molecule to medicine.

Authors:  Richard Kavoussi
Journal:  Eur Neuropsychopharmacol       Date:  2006-06-09       Impact factor: 4.600

Review 4.  Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.

Authors:  Christopher Pittenger; John H Krystal; Vladimir Coric
Journal:  NeuroRx       Date:  2006-01

5.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11
  5 in total
  1 in total

Review 1.  Drug treatment of obsessive-compulsive disorder.

Authors:  Michael Kellner
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.